| NANOVIRICIDES, INC. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | |||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | |||||||
| Price to Sales | |||||||||||||||||||||||||||||||||||||||||||||||||
| Forward Price to Sales MRQ | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||
| Price to Book | 3.37x | 3.29x | 2.96x | 2.09x | 1.98x | 2.16x | 1.77x | 1.30x | 1.00x | 1.22x | .95x | .77x | .68x | .95x | .92x | .98x | 1.51x | 3.13x | 2.91x | 1.31x | 17.10x | 1.80x | 1.53x | 1.10x | 1.69x | 1.60x | 2.71x | 3.62x | 3.86x | ||||||||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||
| Forward Price to Earnings MRQ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||
| Debt to Asset Ratio | .15x | .12x | .10x | .14x | .11x | .07x | .07x | .16x | .12x | .02x | .02x | .02x | .02x | .02x | .03x | .09x | .13x | .34x | .23x | .21x | .17x | .08x | .08x | .05x | .14x | .33x | .27x | .25x | .22x | .39x | .41x | .37x | .37x | .31x | .27x | .28x | .30x | .36x | .34x | .47x | .32x | .69x | |||||||
| Current Ratio | 1.28x | 2.27x | 3.44x | 2.48x | 3.66x | 4.32x | 5.59x | 7.53x | 15.81x | 28.48x | 24.87x | 25.37x | 34.92x | 41.23x | 22.88x | 6.49x | 2.91x | .35x | .50x | .99x | 4.27x | 3.50x | 4.51x | 8.30x | 3.43x | 1.82x | 2.59x | 3.28x | 50.48x | 3.08x | 3.19x | 3.62x | 3.91x | 19.33x | 30.15x | 52.72x | 65.52x | 31.64x | 55.26x | 71.38x | 28.64x | 13.10x | |||||||